)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Greenwich LifeSciences
Greenwich LifeSciences (GLSI) investor relations material
Greenwich LifeSciences Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary26 Oct, 2026
Executive summary
Annual meeting set for December 18, 2026, at 9:00 a.m. ET in New York; shareholders vote on four matters.
Board recommends FOR director elections, auditor ratification and advisory executive compensation; it recommends a 3-year frequency for advisory pay votes.
Voting matters and shareholder proposals
Five director nominees: David B. McWilliams, Snehal S. Patel, Eric Rothe, F. Joseph Daugherty and Kenneth Hallock; Board recommends FOR each.
Proposals include ratification of MaloneBailey LLP for FY ending December 31, 2026, and advisory approval of named executive officer compensation; Board recommends FOR both.
Shareholders are asked to advise on the preferred frequency of executive compensation votes; Board recommends every 3 years.
Board of directors and corporate governance
Five directors stand for election at the 2026 annual meeting, with Board support for all five nominees.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Greenwich LifeSciences
- FLAMINGO-01 expands HLA testing as early data indicate 70-80% lower recurrence.GLSI
Corporate presentation - Board seeks approval of five nominees, auditor, pay, and a three-year say-on-pay cycle.GLSIProxy filing
- Net loss rose to $9.6M as R&D costs surged, with cash boosted by $9.3M in new equity proceeds.GLSIQ2 2026
- Phase III breast cancer vaccine trial expands, showing promise for recurrence prevention and cost savings.GLSINoble Conference
- Phase III breast cancer vaccine trial advances globally, targeting major milestones and partnerships.GLSIVirtual Equity Conference
- Phase III trial of GP2 immunotherapy targets major unmet need in HER2+ breast cancer.GLSICorporate presentation
- At-the-market offering targets $100M for clinical development, with significant dilution risk.GLSIRegistration filing
- Q1 2025 net loss rose to $3.26M as R&D and stock-based compensation expenses increased.GLSIQ1 2025
- Net loss rose to $15.8M in 2024 as R&D spending increased for Phase III trials; cash at $4.1M.GLSIQ4 2024
Next Greenwich LifeSciences earnings date
Q3 202620 Nov, 2026
Greenwich LifeSciences
Next Greenwich LifeSciences earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)